Claude Petit has over two decades of experience in the pharmaceutical industry across the US, Europe, and Asia, focusing on clinical drug development and patient access in various therapeutic areas, including oncology and rare diseases. Currently, Claude serves as AVP of Statistics at Eli Lilly and holds a leadership role with the American Statistical Association to enhance practical leadership skills in biopharmaceutical statistics. Previously, Claude has held executive positions at Boehringer Ingelheim and Astellas Pharma, where they championed cross-regional collaboration and innovative strategies, including the integration of AI in clinical development. Claude earned a PhD in Public Health with a focus on Biostatistics from Universite de medecine du Kremlin Bicetre.
This person is not in the org chart
This person is not in any teams
This person is not in any offices